Interestingly, the researchers also found that by blocking these THBS1 with antibodies the damage could be reversed. These ...

A Stanford-led team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is ...

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep ...

Perspective, Therapeutics (CATX) announced that the first patient was dosed in a new cohort of a Phase 1/2a trial evaluating the safety of ...

India-based Sun Pharmaceutical Industries Limited agreed to acquire U.S.-based immunotherapy and targeted oncology company ...

No mechanism-associated safety issues have been identified for VISTA-blocking antibodies. In addition to its in-house VISTA program, Kineta is focusing discovery stage research efforts on ...

They found that all the antibodies block the receptors the virus uses to bind to host cells and spread infection but with varying efficacy, suggesting the evolution of an equilibrium whereby the ...